Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Boston Scientific (NYSE: BSX) shares ticked up slightly before hours today on fourth-quarter results that beat the consensus ...

Boston Scientific (NYSE:BSX) reported fiscal Q4 2024 results that surpassed analyst expectations. The company's shares swung between gains and losses in premarket trading Wednesday. The company ...

Boston Common Asset Management LLC boosted its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 50.4% during the fourth quarter, according to its most recent Form 13F filing with the ...

Seagate Technology (NASDAQ:STX – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating ...